Cite
HARVARD Citation
Saito, R. et al. (n.d.). 3067 Randomized phase II trial of standard daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer: North Japan Lung Cancer Group Trial NJLCG1102. European journal of cancer. pp. S619-. [Online].